Rockwell Medical (RMTI) Retained Earnings (2010 - 2026)
Rockwell Medical (RMTI) posted Retained Earnings of $440.3 million for Q1 2026, up 209.26% on a QoQ basis from -$403.0 million in Q4 2025, and up 210.3% year-over-year from $141.9 million in Q1 2025.
Rockwell Medical (RMTI) Retained Earnings (2010 - 2026) Analysis & Trends
Rockwell Medical's Retained Earnings history runs 17 years deep, the most recent figure standing at $440.3 million for Q1 2026.
- Quarterly Retained Earnings rose 210.3% year-over-year to $440.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $440.3 million (up 210.3% YoY) and the FY2025 annual result came in at -$403.0 million, down 193.67% from the prior year.
- Retained Earnings was $440.3 million for Q1 2026 at Rockwell Medical, up from -$403.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $440.3 million in Q1 2026 and bottomed at -$403.0 million in Q4 2025.
- A 5-year average of -$35.7 million and a median of -$5000.0 in 2024 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 210.7% in 2025, while the deepest fall reached 8013600.0% in 2025.
- Rockwell Medical's Retained Earnings stood at $402.7 million in 2022, then rose by 3.92% to $418.5 million in 2023, then gained by 2.8% to $430.2 million in 2024, then tumbled by 193.67% to -$403.0 million in 2025, then surged by 209.26% to $440.3 million in 2026.
- Business Quant data shows RMTI's Retained Earnings at $440.3 million in Q1 2026, -$403.0 million in Q4 2025, and $439.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 440.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 440.32 Mn |
| Dec 31, 2025 | -402.99 Mn |
| Sep 30, 2025 | 439.38 Mn |
| Jun 30, 2025 | -400.69 Mn |
| Mar 31, 2025 | -399.19 Mn |
| Dec 31, 2024 | 430.21 Mn |
| Sep 30, 2024 | -396.92 Mn |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 418.49 Mn |
| Sep 30, 2023 | -395.69 Mn |
| Jun 30, 2023 | 137,000.00 |
| Mar 31, 2023 | 402.89 Mn |
| Dec 31, 2022 | 402.70 Mn |
| Sep 30, 2022 | -386.40 Mn |
| Jun 30, 2022 | -382.21 Mn |
| Mar 31, 2022 | -377.24 Mn |
| Dec 31, 2021 | -370.08 Mn |
| Sep 30, 2021 | -361.10 Mn |
| Jun 30, 2021 | -353.56 Mn |